Search

Search Constraints

You searched for: Author/Creator Fancelli, Sara

Search Results

1. Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy. (2022)

2. Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM). Issue 3 (29th March 2021)

3. Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM). Issue 3 (29th March 2021)

4. Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification. (January 2023)

6. Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment. Issue 1 (31st January 2022)

7. Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer. Issue 3 (15th November 2022)

8. PO62 FIRST LINE TRASTUZUMAB-BASED THERAPY IN HER2-POSITIVE METASTATIC BREAST CANCER PATIENTS PRESENTING WITH DE NOVO OR RECURRENT DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY. (November 2015)

9. TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination. (August 2020)